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Abstract
Background: While the immune pathogenesis caused by hepatitis B virus (HBV) infection has been studied extensively, little
is known about direct pathogenic effects of HBV surface proteins. Here, we have investigated pathological cellular effects of
HBV surface protein expression in the liver of transgenic mice with different genetic background.
Methods: The impact of HBV surface protein expression on the liver was studied in two mouse strains, BALB/c and C57BL/6.
Histology and hydroxyproline assays were performed to investigate liver morphology and fibrosis. Gene expression and
signaling were analyzed by microarray, qPCR and Western blotting.
Results: Expression of HBV surface proteins in the liver of transgenic mice induced activation of protein kinase-like
endoplasmic reticulum kinase (PERK) and eukaryotic initiation factor 2a (eIF2a) phosphorylation. Phosphorylation of eIF2a
resulted in activation of the ER stress markers glucose regulated protein (GRP) 78 and pro-apoptotic C/EBP homologous
protein (CHOP) in transgenic mice on BALB/c genetic background leading to stronger liver injury and fibrosis in comparison
with transgenic mice on C57BL/6 background. Hepatic stellate cells represented the main collagen-producing liver cells in
HBV transgenic mice. The key regulators of hepatocyte proliferation, transcription factors c-Jun and STAT3 were activated in
HBV transgenic mice. Tumour incidence in transgenic mice was strain- and sex-dependent.
Conclusions: Extent of liver injury, fibrosis, and tumour development induced by hepatic HBV surface protein expression
considerably depends on host genetic background.
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Introduction
Chronic infection with hepatitis B virus (HBV) affects 350 to
400 million individuals worldwide and is the leading cause of liver
cirrhosis and hepatocellular carcinoma worldwide [1]. Although
much is known about HBV structure and replicative cycle [2] the
pathogenic mechanisms responsible for liver injury, cirrhosis
development and malignant transformation during chronic HBV
infection are not well understood. It is believed that these events
originate from persistent immune pathogenesis [3], but observa-
tions in transgenic mouse models of HBV infection suggest that in
absence of an adaptive immune responses cellular mechanisms
induced by HBV proteins may also lead to the development of
these liver diseases [4,5].
The HBV transgenic mice used in the current study contain a
sub-genomic HBV DNA fragment (genotype D, subtype ayw)
encoding the three co-carboxyterminal HBV surface (HBs)
proteins under the control of the liver-specific murine albumin
promoter [6]. Although these transgenic mice have been shown to
develop chronic liver injury, regenerative hyperplasia, as well as
adenomas and hepatocellular carcinomas (HCC) [7,8] the
mechanisms of HBs proteins pathogenicity are poorly understood.
The HBs protein expression pattern in this mouse model mimics
the situation in the liver of patients with enhanced intracellular
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expression and retention of Hepatitis B virus surface proteins, e. g.
patients with Hepatitis B virus-related chronic liver disease treated
by transplantation. The liver damage in these patients was
attributable to a direct hepatocytotoxic effect of HBV, since they
were on a similar immunosuppresion regime [9,10].
Accumulation of misfolded proteins in the ER activates the
unfolded protein response (UPR) that is sensed by the binding
immunoglobulin protein (BiP)/glucose-regulated protein 78
(GRP78) [11–13]. Distinct branches of UPR are mediated by
three different classes of ER-membrane transducers: inositol-
requiring protein-1 (IRE1), activating transcription factor-6
(ATF6) or protein kinase-like endoplasmic reticulum kinase
(PERK). PERK activation causes the phosphorylation of the
alpha subunit of eukaryotic translation-initiation factor 2 (eIF2a)
[11]. Phosphorylation of eIF2a leads to a reduction in the
initiation of mRNA translation thus reducing the load of new
proteins that require folding in the ER. However, the expression of
some proteins is enhanced. One of them is the C/EBP
homologous protein (CHOP), also known as growth arrest and
DNA damage-inducible gene (GADD) 153 that mediates pro-
apoptotic pathways emanating from the stressed ER [11,14].
Previously it was shown that GRP78 expression was increased in a
human hepatoma cell line that overproduced HBs proteins [15]
and in the liver of transgenic mice that expressed deletion mutant
of large HBs [16].
Hepatic fibrosis constitutes the wound healing response to liver
injury. During fibrosis, hepatic stellate cell (HSC) activation
represents a critical event, because these cells become the primary
source of extracellular matrix in the liver upon damage [17].
Development of hepatic fibrosis after chemical liver injury is
enhanced in BALB/c mice exhibiting a Th2 response compared to
C57BL/6 mice, which demonstrated a primary Th1 response
[18]. Transgenic mice on fibrosis-resistant C57BL/6 genetic
background, which over-produce HBs proteins, develop modest
spontaneous liver fibrosis [19,20].
Transcription factor c-Jun and signal transducer and activator
of transcription (STAT) 3 are implicated in several cellular
processes including proliferation, survival, and cell transformation
[21,22]. They are activated in chemically induced murine liver
tumours and in HCCs of humans [23,24], suggesting an important
function for these proteins in the development of liver tumours.
Here we report that the production of HBV surface proteins
stimulates the expression of CHOP in hepatocytes and could cause
stronger liver damage in transgenic mice on BALB/c genetic
background compared to C57BL/6. Furthermore, HBV trans-
genic mice develop hepatic fibrosis and the level of fibrosis
depends on the genetic background. Although c-Jun transcription
factor up-regulation and activation of STAT3 and PERK in the
liver of transgenic mice might contribute to tumour development,
CHOP expression might reduce tumorigenesis in transgenic mice
on BALB/c genetic background.
Materials and Methods
Animal Model
Transgenic mice were maintained at the Central Animal
Laboratory of the Justus-Liebig-University Giessen under specified
pathogen-free conditions. This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the German law of animal
welfare. The mice received humane care, and all experiments
were approved by the Committee on the ethics of Animal
Experiments of the Regierungspraesidium Giessen, Giessen,
Germany (permit number: V54-19c 20 15 h 01 GI20/10 Nr.
52/2011 and Nr. A5/2012).
Generation and characteristics of transgenic lineages Tg(Alb-
1HBV), internal designation (HBVTg/6) have been described
previously [8]. The HBVTg/6 strain had an inbred C57BL/6
genetic background and was propagated by crossing hemizygous
transgenic males to C57BL/6 females. These mice were
backcrossed to fibrosis susceptible BALB/c genetic background
[18] for at least 6 generations. The obtained transgenic mouse line
was internally designed HBVTg/c. At age of 12, 26, and 52 weeks
mice were killed by CO2-inhalation. Liver samples were collected
and preserved for analyses in accordance with application. Serum
samples were stored at 280uC until analysis of alanine amino-
transferase (ALT) by routine clinical chemistry on a Reflotron Plus
Analyzer (Roche, Mannheim, Germany).
Histology and Hydroxyproline Assay
Immediately after necropsy, liver samples for histology were
fixed in 4% neutral buffered paraformaldehyde at 4uC for 16
hours and embedded in paraffin. Paraffin sections (5 mm) were
stained with hematoxylin and eosin (H&E) or 0.1% Sirius Red
F3B in saturated picric acid (Chroma, Mu¨nster, Germany) for the
detection of collagen fibers [25]. The entire content of collagen
was determined by hydroxyproline (HYP) quantification [26].
Immunohistochemistry
Immunohistochemistry (IHC) was performed using ImmPRESS
Peroxidase Detection Reagents (Vector Laboratories) and anti-
bodies specific for HBsAg (20-HR20), GADD153 (F-168, Santa
Cruz), Desmin and GFAP (Lab Vision), c-Jun (60A8, Cell
Signaling), BiP (C50B12, Cell Signaling). Colour reaction was
developed with VECTOR VIP Peroxidase Substrate Kit or DAB
Peroxidase Substrate Kit, (Vector Laboratories). The percentage
of BiP, Desmin, and GFAP-positive area was determined using
ImageJ image analysis system (National Institutes of Health,
Bethesda, MD, USA).
Western Blot Analysis
Total liver lysates were analyzed by immunoblotting using
antibodies against HBsAg (20-HR20, Fitzgerald), GADD153 (F-
168, Santa Cruz), phospho-PERK (16F8, Cell Signaling), PERK
(H-300, Santa Cruz), phospho-eIF2a (119A11, Cell Signaling),
eIF2a (L57A5, Cell Signaling), b-actin (13E5, Cell Signaling),
JNK2 (N-18, Santa Cruz), c-Jun (60A8, Cell Signaling), phospho-
c-Jun (D47G9, Cell Signaling), phospho-SAPK/JNK (81E11, Cell
Signaling), STAT3 (79D7, Cell Signaling), phospho-STAT3
(D3A7, Cell Signaling).
Assay for HBV-specific proteins
HBsAg was measured in serum and in liver lysates by an in-
house sandwich ELISA as described [27]. HBsAg amount per
hepatocyte was calculated based on the hepatocellularity number
for mouse 135 million cells per gram of liver [28].
Quantitative real-time PCR (qPCR)
RNA isolation, cDNA synthesis, qPCR and quality control of all
steps were performed as described previously [29]. Primers were
purchased from QIAGEN (Hilden, Germany). qPCR data were
analysed using DDCt method [30].
Microarray analysis
Microarray experiments were performed with total RNA from
the liver of 12-week-old mice as described previously [31]. The
Pathological Impact of HBV Surface Proteins
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data presented here have been deposited in NCBI’s Gene
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/)
and are accessible through GEO Series accession number
GSE40826.
Statistical analysis
Statistical analysis was performed with SPSS V.17.0 software
(SPSS Inc.). For non-normally distributed parameters, Mann-
Whitney U test and Spearman rank test were applied. The results
are presented as mean6SEM. A two-sided p,0.05 was considered
significant (shown as * in the figures].
Results
Liver damage induced by HBs proteins expression
depends on host genetic background
Transgenic mice were sacrificed at week 12, 26, and 52. To
estimate the level of liver cell damage we have measured alanine
transaminase (ALT) in serum. Activities of serum ALT were
markedly increased already in 12-week-old HBVTg/c mice
compared to the wild-type and remained at that level during the
observation period. In HBVTg/6 mice the ALT elevation was
moderate at week 12 but increased later to levels almost as high as
in HBVTg/c mice (Figure 1A). Histological analysis revealed no
significant lymphocyte infiltration of the liver from 12-week-old
transgenic mice (Figure S1A). Furthermore, amounts of HBsAg
per hepatocyte in 12-week-old mice were similar: 0.42 pg/cell
(range, 0.18–0.71 pg/cell; n = 5) for HBVTg/c and 0.31 pg/cell
(range, 0.15–0.64 pg/cell; n = 5) for HBVTg/6. Immunohisto-
chemical and Western blot analyses of livers from transgenic mice
also showed that distributions and expression levels of HBs
proteins were similar in mice on both C57BL/6 and BALB/c
genetic backgrounds (Figure S1B and S2). Moreover, amounts of
HBsAg in serum of transgenic mice did not differ significantly:
2.02 ng/ml (range, 0.68–3.19 ng/ml; n = 5) for HBVTg/c and
1.34 ng/ml (range, 0.68–2.55 ng/ml; n = 4) for HBVTg/6. Thus,
the elevated serum ALT levels in HBVTg/c mice could be a
consequence of a specific host response to the presence of HBs
proteins.
To identify the pathways which are activated in the HBs-
expressing liver tissue we carried out transcriptional profiling using
microarray analysis. As illustrated in Table 1 a set of genes that is
known to be induced by UPR is up-regulated in the liver of 12-
week-old transgenic mice. Interestingly, the expression of gene
ddit3 that encodes CHOP protein is stronger up-regulated in the
liver of HBVTg/c mice compared to HBVTg/6. To confirm this
finding we studied the expression of CHOP by qRT-PCR and
Western blot analysis. Transcription of the ddit3 gene was strongly
activated in 12-week-old HBVTg/c mice and declined thereafter
with age, whereas in HBVTg/6 mice ddit3 transcription was rather
weakly enhanced in 12-week-old mice and increased with age
(Figure S3). Western blot analysis of liver proteins revealed that
CHOP was up-regulated much stronger in HBVTg/c mice
compared to HBVTg/6 (Fig. 1B). Selective CHOP translation
depends on eIF2a phosphorylation by PERK after induction of
UPR [11]. However, we detected similar level of PERK activation
and eIF2a phosphorylation in the liver from both mouse strains
irrespective of gender and age (Fig. 1C and D). Interestingly, other
UPR sensors ATF6 and IRE1 as well as eIF2a kinases PKR
(protein kinase R) and GCN2 (general control non-derepressible-2)
[32] were not activated in the liver of transgenic mice (data not
shown). Taken together, expression of HBs proteins in the liver of
transgenic mice leads to the specific activation of the PERK
branch of UPR in hepatocytes from both mouse strains, but
expression of CHOP was much stronger in HBVTg/c mice.
Enhanced translation of CHOP results in liver damage and could
explain higher serum ALT levels in HBVTg/c mice.
To examine the location of CHOP expressing hepatocytes
immunohistochemistry (IHC) was performed. According to our
previous finding a significant part of hepatocytes from 12-week-old
HBVTg/c mice accumulated CHOP in the nucleus and the
amount of CHOP-positive hepatocytes declined with age, whereas
we could detect only a few hepatocytes in HBVTg/6 liver
positively stained for CHOP independent of age (Figure 2A).
Interesting, CHOP-positive hepatocytes were located in centri-
lobular areas which surround a hepatic central vein (Figure 2A).
Furthermore, induction of UPR leads to activation of the major
sensor of unfolded protein accumulation BiP/GRP78 [12]. IHC
demonstrated strong expression of BiP in selected hepatocytes in
centrilobular areas (Figure 2B and Figure S4), although Western
blot analysis did not reveal any differences between wild-type and
transgenic mice in expression of BiP/GRP78 (data not shown).
Thus, expression of HBs proteins activated the UPR downstream
pathway (CHOP and BiP) much stronger in the liver of transgenic
mice on BALB/c genetic background compared to C57BL/6.
This activation is located in centrilobular zones of the liver.
Liver fibrosis
Measurement of liver hydroxyproline content demonstrated the
development of hepatic fibrosis in transgenic mice (Figure 3A).
Enhanced hepatic fibrosis was confirmed by Sirius red staining as
well. We observed minimal fibrosis in the liver of 12-week-old
mice. But fibrosis constantly increased with age. However,
HBVTg/c mice accumulated more collagen (Figure S5). Hepatic
stellate cells (HSC) are the primary effector cells responsible for the
deposition of ECM in normal and fibrotic liver [33]. Therefore,
we tested the expression of HSC activation markers. We detected
increased amounts of GFAP- and desmin- positive cells in the liver
of transgenic mice, thus demonstrating HSC proliferation in the
liver of transgenic mice (Figure 3B and Figure S6). Moreover,
double staining of desmin with specific antibodies and collagen
with Sirius red has shown co-localization of HSCs with collagen
fibres (Figure S7). Taken together, expression of HBs proteins in
mouse liver induces development of hepatic fibrosis, which
correlated with liver injury. HSCs might be the main collagen-
producing cells in this mouse model.
HBs protein-induced tumour development depends on
host genetic background
Microarray analysis showed an up-regulation of c-jun gene
expression in transgenic mice independent of genetic background
(Table 1). These results were confirmed using qPCR. Maximal
expression was detected in the liver of 52-week-old mice (Figure
S8). Expression of c-Jun protein was increased in the liver of 12-,
26-, and 52-week-old transgenic mice (Figure 4A). Major parts of
hepatocytes of 52-week-old mice accumulated c-Jun in the nucleus
(Figure S9). Phosphorylation of c-Jun by c-Jun N-terminal kinase
(JNK) stimulates its ability to activate transcription [34,35].
Western blot analyses demonstrated that JNKs were activated
(Figure 4B) and the level of c-Jun phosphorylation was indeed
increased in the liver of 52-week-old transgenic mice (Figure 4C).
Thus, expression of HBs proteins in the liver of transgenic mice
leads to activation of c-Jun expression.
STAT3 activation was observed in mouse models of liver injury
and in human liver diseases in the context of inflammation and
cancer [22]. Therefore, we examined the status of STAT3
activation in the liver of HBV transgenic mice. Western blot
analysis of liver protein extracts revealed STAT3 activation in the
Pathological Impact of HBV Surface Proteins
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liver of male but not female mice (Figure 4D). Thus, expression of
HBV surface proteins in the liver of transgenic mice results in
STAT3 activation in a gender-dependent manner.
Up-regulation of c-Jun expression and STAT3 activation could
promote hepatic tumour growth [21,22]. We checked transgenic
mice for occurrence of liver tumour. In young mice (12- and 26-
week-old) mice we could detect no tumours. However, they were
detected in 100% (6/6) of 52-week-old male and 20% (1/5) of
female HBVTg/6 mice, whereas only 58% (7/12; X2= 3.46;
p = 0.06) of 52-week-old male and 0% (0/6) of female HBVTg/c
mice develop tumours. Hence, development of tumours in HBV
transgenic mice was age-, gender-, and strain-dependent.
Discussion
In this study we investigated the effects of HBVs proteins
expression in the liver of transgenic mice BALB/c and C57BL/6
genetic background. Since we observed only weak strain-
independent immune cell infiltration of transgenic mice liver
(Figure S1) this model could be considered as one with impaired
immune reaction. One important negative impact of immune
deficiency on chronic HBV infection in human is related to the
direct cytotoxicity of high levels of HBs and other HBV proteins
[9,10,36]. Low serum HBsAG titers were associated with strong
intracellular accumulation of HBs in HBV transgenic mice on
both genetic backgrounds. This condition was also seen in some
patients with late phases of chronic HBV infection [37,38]. Thus,
transgenic mice expressing HBs proteins reflect the situation in the
liver of HBV-infected patients demonstrated strong retention of
HBsAg in hepatocytes.
Higher serum ALT activities in HBVTg/c mice suggest
stronger liver injury compared to HBVTg/6 (Figure 1A). Since
the level of cellular infiltration was low in the liver of transgenic
mice on both genetic backgrounds we searched for other reasons
of hepatocyte death. Increased CHOP expression as a result of
prolonged ER stress promotes cell death, whereas CHOP deletion
protects against the death of ER-stressed cells [14]. Strongly
increased transcription and protein accumulation of CHOP in
HBVTg/c mice (Figure 1B and 2A; Figure S3) inducing
hepatocyte death could explain increased serum ALT level in
these mice. Expression of CHOP is mediated by phosphorylation
of eIF2a [32] that in turn is phosphorylated by PERK [11].
Interestingly, levels of PERK activation and eIF2a phosphoryla-
tion were similar in the liver of both HBV transgenic mouse strains
(Figure 1C and 1D). Two other branches of UPR IRE1a and
ATF6 were not activated in the liver of HBV transgenic mice (data
not shown). PERK branch activation is largely sustained with
unmitigated ER stress, whereas persistent ER stress attenuates
IRE1a and ATF6 signaling [39]. Therefore, permanent expres-
sion of HBs proteins leads to the activation of persistent ER stress
in hepatocytes that induces PERK and impairs another branches
Figure 1. HBs proteins-induced liver injury depends on host genetic background. (A) Assessment of liver damage in wild-type and HBV
transgenic mice. ALT was measured in serum of 12-, 26-, and 52-week-old mice (mean6SEM, n = 5–10). (B-D) Western blot analysis of total protein
lysates from the liver of 12-, 26-, and 52-week-old mice was performed using (B) anti-CHOP/GADD153, (C) anti-phospho-PERK, and (D) anti-phospho-
eIF2a (Ser51) antibodies. Equal protein loading was confirmed with anti-PERK (B), anti-eIF2a (C), and anti-b-actin (D) antibodies. 1 – female BALB/c;
2,3 – female HBVTg/c; 4 – male BALB/c; 5, 6 – male HBVTg/c; 7 – female C57BL/6; 8, 9 – female HBVTg/6; 10 – male C57BL/6; 11, 12 – male HBVTg/6
mice.
doi:10.1371/journal.pone.0090608.g001
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Table 1. Selected hepatic genes significantly differentially expressed in the liver of 12-week-old HBV transgenic mice.
Accession
Primary Sequence
Name Sequence Description Fold Change HBVTg/c
Fold Change
HBVTg/6
NM_019738 Nupr1 Nuclear protein 1 14.97 5.44
NM_007498 Atf3 Activating transcription factor 3 9.53 3.25
NM_007837 Ddit3 DNA-damage inducible transcript 3 6.39 2.14
NM_024440 Derl3 Der1-like domain family, member 3 8.52 1.44
NM_016773 Nucb2 Nucleobindin 2 4.16 1.81
NM_012055 Asns Asparagine synthetase 4.14 2.28
NM_007836 Gadd45a Growth arrest and DNA-damage-inducible 45 alpha 2.61 1.07
NM_144554 Trib3 Tribbles homolog 3 2.18 21.13
NM_013560 Hspb1 Heat shock protein 1 2.14 2.01
NM_022310 Hspa5 Heat shock 70 kD protein 5 (GRP78) 2.08 1.19
NM_011631 Hsp90b1 Heat shock protein 90 kDa beta (Grp94) 1.91 21.05
NM_011817 Gadd45g Growth arrest and DNA-damage-inducible 45 gamma 21.67 2.18
NM_010591 Jun Jun oncogene 4.17 2.30
NM_008182 Gsta2 Glutathione S-transferase, alpha 2 (Yc2) 3.20 2.04
NM_031170 Krt2-8 Keratin complex 2, basic, gene 8 2.21 1.95
NM_007742 Col1a1 Procollagen, type I, alpha 1 2.00 1.48
NM_007743 Col1a2 Procollagen, type I, alpha 2 1.94 1.23
NM_011594 Timp2 Tissue inhibitor of metalloproteinase 2 1.75 21.04
NM_010664 Krt1-18 Keratin complex 1, acidic, gene 18 1.81 1.80
doi:10.1371/journal.pone.0090608.t001
Figure 2. Expression of CHOP/GADD153 and BiP/GRP78 in the liver of HBV transgenic mice. Immunohistochemical analysis of paraffin-
embedded liver sections from 12-, 26-, and 52-week-old mice was performed using specific anti-CHOP/GADD153 (A) and anti-BiP (B) antibodies. 100x-
original magnification 1006, bar = 200 mm. 200-original magnification 2006, bar = 100 mm. *-central vein. #-periportal vein.
doi:10.1371/journal.pone.0090608.g002
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of UPR. It is possible that this situation is common for chronic
liver disease comprising ER stress induction.
It was previously shown that despite PERK activation and
eIF2a phosphorylation in the liver of patients with nonalcoholic
fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH), downstream effectors such as CHOP remain inactive
[40]. A similar situation was observed in the liver of HBV
transgenic mice on C57BL/6 genetic background. However,
stimulation of CHOP and BiP expression in HBVTg/c mice
demonstrated that the outcome of UPR induction depends on the
genetic background of subjects. Furthermore, several studies have
demonstrated that PERK function is critical for maintaining
cellular redox homeostasis, promotes cancer cell proliferation and
tumour growth [41]. Thus, sustained activation of PERK could
also promote cancer development in the liver of HBV transgenic
mice.
Global reduction of translation initiation due to PERK-
mediated eIF2a phosphorylation [32] should also affect the
expression of HBs proteins in the liver. This suggests the following
feed-back mechanism: PERK activation results in the reduction of
HBs translation and that leads to a balance between PERK
activation and HBs protein synthesis in hepatocytes.
Development of tumours in HBV transgenic mice as it was
shown by us and others [8] is age-, gender-, and strain-dependent.
In this study we observed a strong up-regulation of c-Jun hepatic
expression and an activation of STAT3, whose role in tumori-
genesis is well established [22,23,42]. Jun controls liver cancer
initiation and is required for development of chemically induced
HCC [23]. Interestingly, transgenic mice comprising the whole or
partial HBV genome are also more susceptible to chemically
induced hepatocarcinogenesis [43,44]. Likewise, hepatitis C virus
core protein potentiates chemically induced HCC through c-Jun
and STAT3 activation [45]. Thus, stimulation of c-Jun expression
and STAT3 activation by HBs proteins could promote the
development of liver cancer induced by different causes, such as
sustained inflammation, activation of oncogenes etc. Furthermore,
the finding that STAT3 was activated in male mice only correlated
with our observation that tumour development in HBV transgenic
mice is gender-dependent. There is accumulating evidence that
tumour-specific ER stress can be exploited for cancer therapy by
treatment with ER stress-aggravating compounds [46]. Moderate,
transient ER stress response represents an adaptive mechanism to
support cellular survival. However, severe and excessive stress
conditions could turn this response system to its pro-apoptotic
mode. Stimulation of CHOP expression in HBVTg/c mice
indicated an activation of pro-apoptotic cellular stress responses in
the liver and resulted in reduced tumour incidence in 52-week-old
HBVTg/c mice.
Taken together, the outcome of HBV surface proteins
expression in the liver of transgenic mice depends on the host
genetic background. Liver injury and fibrosis were increased in
transgenic mice on BALB/c background compared to C57BL/6
correlating with strong expression of PERK downstream pro-
apoptotic effector CHOP. More interesting finding is genetic
background-independent stimulation of c-Jun expression together
with STAT3 and PERK activation promoting cancer cell
proliferation and tumour growth. However, activation of pro-
apoptotic cellular stress response could result in reduced tumour
incidence in the liver.
Supporting Information
Figure S1 Representative liver histology and distribu-
tion of HBs proteins in hepatocytes of transgenic mice.
(A) H&E staining of liver sections from 12-, 26-, and 52-week-old
mice HBVTg/c and HBVTg/6 mice. Original magnification
1006, bar = 200 mm. Insets – H&E staining of liver from
corresponding wild-type mice. (B) Paraffin-embedded sections of
transgenic mice liver were stained with an antibody against
HBsAg. Original magnification 1006, bar = 200 mm.
(TIF)
Figure S2 Expression of HBs proteins in the liver of
transgenic mice. Western blot analysis of total protein lysates
from livers of HBV transgenic mice using specific anti-HBsAg
antibody. 1- female BALB/c; 2,3- female HBVTg/c; 4 – male
BALB/c; 5, 6 – male HBVTg/c; 7 – female C57BL/6; 8, 9 –
female HBVTg/6; 10 – male C57BL/6; 11, 12 – male HBVTg/6
mice. Equal protein loading was confirmed with anti-b-actin
antibody.
(TIF)
Figure S3 Transcriptional up-regulation of ddit3 gene in
the liver of HBV transgenic mice. All data are normalized to
Figure 3. Fibrogenesis in the liver of HBV transgenic mice. (A)
Entire collagen was assessed by measurement of hydroxyproline (HYP)
in murine liver (mean6SEM, n = 5–10). (B) Activation of hepatic stellate
cells in HBV transgenic mice. Paraffin-embedded liver sections of 26-
week-old HBVTg/c mice were analysed using anti-GFAP (left panel) and
anti-Desmin (right panel) antibodies. Inserts - immunohistochemical
analysis of the liver from wild-type BALB/c mouse. 1006 - original
magnification 1006, bar = 200 mm. 2006– original magnification 2006,
bar = 200 mm.
doi:10.1371/journal.pone.0090608.g003
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r18S. Fold increase to wild-type animals is depicted (mean 6
SEM, n= 5–10).
(TIF)
Figure S4 Quantification of BiP expression in the liver
of HBV transgenic mice. Percentage of BiP-positive area in the
whole image was estimated with ImageJ software (mean6SEM,
n=5).
(TIF)
Figure S5 Development of fibrosis in the liver of HBV
transgenic mice. Collagen fibres are detected in polarized light
after Sirius red staining of 5-mm paraffin-embedded liver sections
of 12-, 26-, and 52-week-old HBVTg/c and HBVTg/6 mice.
Original magnification 1006, bar = 200 mm. Insets – Sirius red
staining of the liver from wild-type mice.
(TIF)
Figure S6 Quantification of Desmin and GFAP expres-
sion in the liver of HBV transgenic mice. Percentages of
Desmin (A) and GFAP (B)-positive areas in the whole images were
estimated with ImageJ software (mean6SEM, n= 5).
(TIF)
Figure S7 Hepatic stellate cells are major contributor to
hepatic fibrosis in HBV transgenic mice. Paraffin-embed-
ded liver section from 26-week-old HBVTg/c mouse was first
stained with anti-Desmin antibody and subsequently with Sirius
red. Collagen fibres are detected in polarized light, Desmin-
positive staining appears in black. Original magnification 2006,
bar = 100 mm.
(TIF)
Figure S8 Transcriptional up-regulation of c-jun gene in
the liver of HBV transgenic mice. All data are normalized to
r18S. Fold increase to wild-type animals is depicted (mean 6
SEM, n= 5–10).
(TIF)
Figure S9 Expression of Jun protein in the liver of HBV
transgenic mice. Immunohistochemical analysis of paraffin-
embedded liver sections from 52-week-old mice was performed
using specific anti-Jun antibody. Original magnification 1006, bar
= 200 mm.
(TIF)
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